Skip to main content

Table 3 Clinical outcomes and foot health and functionality of the intervention group, and within-group difference (baseline to 12 weeks)

From: Foot-ankle functional outcomes of using the Diabetic Foot Guidance System (SOPeD) for people with diabetic neuropathy: a feasibility study for the single-blind randomized controlled FOotCAre (FOCA) trial I

Outcomes Intervention group Changes in outcomes
Baseline (n = 6) T12 (n = 6) Difference (95%CI)
MNSI Questionnaire (0–13) 8.8 (2.6) 8.3 (1.2) − 0.5 (− 2.5 to 1.5)
FHSQ—foot pain (0–100) 38.6 (35.8) 66.2 (29.7) 27.6 (6.4 to 48.7)
FHSQ—foot function (0–100) 68.7 (35.9–90.6)a 90.6 (20.3–100.0)a 3.1 (− 16.9 to 27.3)a
FHSQ—footwear (0–100) 27.7 (32.7) 70.8 (29.2) 43.1 (− 7.1 to 93.2)
FHSQ—general foot health (0–100) 12.5 (0.0–34.3)a 12.5 (0.0–74.3)a 0.0 (− 22.0 to 35.3)a
  1. Data are presented as mean (SD) and difference with 95% confidence intervals. a Represents median (interquartile range) and median of differences with 95% confidence intervals. MNSI Michigan Neuropathy Screening Instrument, FHSQ Foot Health Status Questionnaire, DPN diabetic peripheral neuropathy